Non Animal Testing Database
EnglischDeutsch

3D bioprinted vascularized breast tumor model

October 2022
Penn State University, University Park, USA
Despite substantial advancements in the development of cancer treatments, the lack of standardized and physiologically-relevant in vitro testing platforms limit the early screening of anticancer agents. A major barrier is the complex interplay between the tumor microenvironment and immune response. To tackle this, a dynamic-flow-based 3D bioprinted multi-scale vascularized breast tumor model, responding to chemo and immunotherapeutics was developed. Heterotypic tumors were precisely bioprinted at pre-defined distances from a perfused vasculature, exhibiting tumor angiogenesis and cancer cell invasion into the perfused vasculature. Bioprinted tumors treated with varying dosages of a chemotherapy medication portrayed a dose-dependent drug response behaviour. Furthermore, a cell-based immune therapy approach was explored, resulting in up to ≈70% reduction in tumor volumes. The presented platform paves the way for a robust, precisely fabricated, and physiologically-relevant tumor model for the future translation of anti-cancer therapies to personalized medicine.
Chemotherapeutics and CAR-T cell-based immunotherapeutics screening on a 3D bioprinted vascularized breast tumor model
Ibrahim T. Ozbolat
#1630
Added on: 11-25-2022
Back to Top
English German

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!